1
ABBOTT LABORATORIES (PAKISTAN) LIMITED
STATEMENT OF FINANCIAL POSITION
AS AT DECEMBER 31, 2024
2024 | 2023 | 2024 | 2023 | ||
Note …….… (Rupees '000) ………. | Note ……... (Rupees '000) ……… | ||||
EQUITY AND LIABILITIES | ASSETS |
SHARE CAPITAL
AND RESERVES | |
Authorised capital | 3 |
Issued, subscribed and |
2,000,000
NON-CURRENT ASSETS | ||
2,000,000 Property, plant and equipment | 11 | |
Intangible assets | 12 | |
14,252,797
1,250
13,375,186
12,678
paid-up capital | 4 |
Reserves - capital | |
Reserves - revenue | |
Total equity | |
NON-CURRENT LIABILITIES | |
Deferred taxation - net | 5 |
Staff retirement benefits | 6 |
Lease liabilities | 7 |
Total non-current liabilities | |
CURRENT LIABILITIES | |
Trade and other payables | 8 |
Unclaimed dividends | |
Unpaid dividends | |
Current maturity of | |
lease liabilities | 7 |
Provisions | 9 |
Total current liabilities | |
CONTINGENCIES AND | |
COMMITMENTS | 10 |
979,003
1,750,481
20,995,152
23,724,636
1,052,587
1,184,179
29,545
2,266,311
10,951,662
63,715
-
22,683
622,151
11,660,211
979,003
1,437,162
15,821,181
18,237,346
519,569
1,049,089
52,228
1,620,886
15,091,467
64,676
1,029,503
105,990
543,577
16,835,213
Long-term loans and advances | 13 |
Long-term deposits | |
Long-term prepayments | |
Total non-current assets | |
CURRENT ASSETS | |
Stores and spares | 14 |
Stock-in-trade | 15 |
Trade debts | 16 |
Loans and advances | 17 |
Trade deposits and | |
short-term prepayments | 18 |
Other receivables | 19 |
Taxation - net | |
Cash and cash equivalents | 20 |
Total current assets |
114,226
7,513
13,710
14,389,496
529,619
10,694,515
2,982,679
938,021
283,813
1,182,530
468,136
6,182,349
23,261,662
95,423
7,513
3,427
13,494,227
462,670
12,826,865
1,649,512
472,735
320,399
2,044,254
386,071
5,036,712
23,199,218
TOTAL EQUITY AND LIABILITIES 37,651,158 36,693,445 TOTAL ASSETS | 37,651,158 36,693,445 | ||||||
The annexed notes 1 to 43 form an integral part of these financial statements.
Chief Executive Officer | Director | Chief Financial Officer |
1 |
ABBOTT LABORATORIES (PAKISTAN) LIMITED |
STATEMENT OF CASH FLOWS |
FOR THE YEAR ENDED DECEMBER 31, 2024 |
Note |
CASH FLOWS FROM OPERATING ACTIVITIES |
20242023
…………. (Rupees '000) ………….
Cash generated from operations | 30 |
Income tax paid | |
Minimum tax differential paid | |
Final taxes paid | |
Long-term loans and advances - net | |
Long-term prepayments - net | |
Contributions to staff retirement benefit funds | 6.7 |
Net movement in provisions | |
Net cash generated from / (used in) operating activities | |
CASH FLOWS FROM INVESTING ACTIVITIES | |
Additions to property, plant and equipment | |
Sale proceeds from disposal of operating fixed assets | 11.5 |
Interest income | |
Net cash used in investing activities | |
CASH FLOWS FROM FINANCING ACTIVITIES | |
Bank charges paid | 27 |
Interest portion of lease liabilities paid | 7.1 |
Principal portion of lease liabilities paid | |
Dividends paid | 31 |
Net cash used in financing activities | |
Net increase / (decrease) in cash and cash equivalents | |
Cash and cash equivalents at the beginning of the year | |
Cash and cash equivalents at the end of the year | 20 |
The annexed notes 1 to 43 form an integral part of these financial statements.
8,356,459
(3,325,706)
(105,530)
-
(18,803)
(10,283)
(300,648)
78,574
4,674,063
(3,022,082)
181,547
472,177
(2,368,358)
(11,875)
(11,739)
(105,990)
(1,030,464)
(1,160,068)
1,145,637
5,036,712
6,182,349
3,176,942
(2,311,498)
(525,397)
(22,505)
(28,914)
(2,781)
(275,552)
(72,599)
(62,304)
(3,074,518)
139,846
735,631
(2,199,041)
(8,115)
(22,175)
(89,069)
(1,374,413)
(1,493,772)
(3,755,117)
8,791,829
5,036,712
Chief Executive Officer | Director | Chief Financial Officer |
1
ABBOTT LABORATORIES (PAKISTAN) LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED DECEMBER 31, 2024
Reserves | |||||||||||||
Issued, | |||||||||||||
Capital reserves | Revenue reserves | ||||||||||||
subscribed | Total equity | ||||||||||||
and paid- | Reserve | Share based | Total | ||||||||||
General | Un-appropriated | ||||||||||||
up capital | arising on | compensation | |||||||||||
reserve | profit | ||||||||||||
merger | reserve | ||||||||||||
-------------------------------------------------------------- | (Rupees '000) -------------------------------------------------------------- | ||||||||||||
Balance as at January 01, 2023 | 979,003 | 46,097 | 1,012,542 | 5,338,422 | 9,729,965 | 16,127,026 | 17,106,029 | ||||||
Employee benefit cost under IFRS 2 - 'Share-based payments' | - | - | 378,523 | - | - | 378,523 | 378,523 | ||||||
Total comprehensive income for the year ended December 31, 2023 |
Profit for the year
Other comprehensive income for the year - net of tax
Total comprehensive income for the year
Balance as at December 31, 2023
Balance as at January 01, 2024
Employee benefit cost under IFRS 2 - 'Share-based payments'
Total comprehensive income for the year ended December 31, 2024
- | - | - | - | 261,777 | 261,777 | 261,777 | ||||||
- | - | - | - | 491,017 | 491,017 | 491,017 | ||||||
- | - | - | - | 752,794 | 752,794 | 752,794 | ||||||
979,003 | 46,097 | 1,391,065 | 5,338,422 | 10,482,759 | 17,258,343 | 18,237,346 | ||||||
979,003 | 46,097 | 1,391,065 | 5,338,422 | 10,482,759 | 17,258,343 | 18,237,346 | ||||||
- | - | 313,319 | - | - | 313,319 | 313,319 |
Profit for the year
Other comprehensive loss for the year - net of tax
Total comprehensive income for the year
Balance as at December 31, 2024
- | - | - | - | 5,234,233 | 5,234,233 | 5,234,233 | ||||||
- | - | - | - | (60,262) | (60,262) | (60,262) | ||||||
- | - | - | - | 5,173,971 | 5,173,971 | 5,173,971 | ||||||
979,003 | 46,097 | 1,704,384 | 5,338,422 | 15,656,730 | 22,745,633 | 23,724,636 | ||||||
The annexed notes 1 to 43 form an integral part of these financial statements.
Chief Executive Officer | Director | Chief Financial Officer |